Back

Unmasking risk in asymptomatic hypertrophic cardiomyopathy: clinical and multimodality imaging determinants of disease progression and adverse outcomes

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in myocardial disease Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Susan Keen

Cleveland Clinic, Cleveland (United States of America)

6 More presentations in this session

Presentation thumbnail
A novel prediction model for heart failure-related death in hypertrophic cardiomyopathy
Doctor Y. Zhang (Beijing, CN)
Abstract
Presentation thumbnail
Lifetime risk of cardiomyopathy in the general population: a nationwide cohort study from Sweden
Doctor E. Linner (Lund, SE)
Abstract
Presentation thumbnail
Phenotype- and genotype-specific dominance of arrhythmic versus heart failure trajectories in inherited cardiomyopathies
Assistant Professor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Genetic test yield in non-dilated left ventricular cardiomyopathy
Doctor A. Faggiano (Milan, IT)
Abstract
Presentation thumbnail
Machine-learning clustering uncovers divergent response pathways to mavacamten in obstructive HCM: a portuguese multicentre perspective
Doctor I. Miranda (Amadora, PT)
Abstract

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in myocardial disease

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Novel thresholds for all-cause mortality risk stratification in hypertrophic cardiomyopathy using cardiac magnetic resonance- late gadolinium enhancement
1 September 2025
thumbnail
Congress Presentation
Prevalence and clinical impact of latent obstruction in hypertrophic cardiomyopathy
9 December 2021
thumbnail
Congress Presentation
Use of advanced echocardiographic modalities to discriminate preclinical HCM mutation carriers from non-carriers
26 August 2022
thumbnail
Congress Presentation
Sex disaggregated analysis of risk factors for adverse outcomes in hypertrophic cardiomyopathy
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources